About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Change in Airway Responsiveness After Allergen Exposure

NCT01699594·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University of Saskatchewan

Age

18–65

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

mild, allergic asthma
FEV1 greater than 70% predicted
methacholine PC20 less than or equal to 16mg/ml

You may not be if

known sensitivity to mannitol or other excipient
diagnosis of any other respiratory or non respiratory disease/disorder that would preclude the individual from participating
recent thoracic, abdominal or eye surgery
recent allergen exposure (4 weeks), respiratory infection (6 weeks)
current immunotherapy
pregnancy
history of anaphylaxis
use of asthma therapies other than short acting beta agonist

The record

StatusCompleted

PhaseNo phase

Taking part11

StartedOct 2012

UpdatedApr 9, 2015

Conditions

Allergic Asthma

Where1

University of Saskatchewan
Saskatoon, Saskatchewan, Canada

Clareo Health | Change in Airway Responsiveness After Allergen Exposure